Merck’s challenge to medicare drug pricing could cause ‘narrative shift’ in pharma, says Jared Holz

June 7, 2023
Merck’s challenge to medicare drug pricing could cause ‘narrative shift’ in pharma, says Jared HolzMerck’s challenge to medicare drug pricing could cause ‘narrative shift’ in pharma, says Jared Holz
Share This

Jared Holz, Mizuho healthcare sector specialist, joins ‘Fast Money’ to discuss Merck’s lawsuit against the federal government over Medicare drug pricing.

Latest Mizuho News

The Energy Department's '$17 billion question' around nuclear energy

The Energy Department's '$17 billion question' around nuclear energy

June 29, 2026
Robinhood could be first ‘hyperscaler’ of online brokerages, says Mizuho’s Dan Dolev

Robinhood could be first ‘hyperscaler’ of online brokerages, says Mizuho’s Dan Dolev

July 2, 2026
Why SpaceX's future depends on Starship

Why SpaceX's future depends on Starship

July 20, 2026

Mizuho news from around the globe

back-to-top-blue